Cytek Biosciences, Inc.CTKBNASDAQ
Loading
Gross Profit Over TimeStrong
Percentile Rank67
3Y CAGR+1.1%
5Y CAGR+15.1%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+1.1%/yr
Annual compound
5Y CAGR
+15.1%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
2025$104.46M-6.0%
2024$111.11M+1.5%
2023$109.43M+8.4%
2022$100.97M+27.6%
2021$79.14M+53.1%
2020$51.71M+80.3%
2019$28.67M-